Suzuki Hisashi, Kiyoshima Moriyuki, Kitahara Miyuki, Asato Yuji, Amemiya Ryuta
Department of Thoracic Surgery, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, Japan.
Department of Thoracic Surgery, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, Japan.
Ann Thorac Surg. 2015 Feb;99(2):435-40. doi: 10.1016/j.athoracsur.2014.09.027. Epub 2014 Dec 10.
Surgical resection has been widely performed on patients with pulmonary metastases from colorectal cancer with favorable outcomes. However, there are currently no standard surgical indications for pulmonary metastases.
We reviewed 94 patients who underwent complete resection of pulmonary metastases from colorectal cancer between November 1991 and April 2013. The cumulative survival rate after pulmonary metastasectomy was calculated, and prognostic factors for long-term survival were analyzed.
There were 60 men and 34 women, and their median age was 66 years. The 5-year survival rate was 45.5% after pulmonary metastasectomy. The 5-year survival of patients with colon and rectal cancers was 62.4% and 33.8%, respectively (p = 0.030), and the 5-year survival of those with normal and high carcinoembryonic antigen (CEA) levels before pulmonary resection was 57.0% and 30.9%, respectively (p = 0.038). Multivariate analysis revealed the preoperative CEA level was an independent prognostic factor. Recurrence was identified in 65 of the 94 patients (69.1%) after pulmonary metastasectomy, and the patients who underwent surgical resection for recurrent lesions in the liver or lungs, or both, had better survival than those who received other treatments or palliative care.
Surgical resection offers a chance to prolong survival in colorectal cancer patients with resectable pulmonary metastases. Owing to the high recurrence rate, careful postoperative follow-up for early detection is recommended, and even for recurrence, surgical resection should be considered for better survival if the lesions are limited to the liver or lungs, or both.
手术切除已广泛应用于结直肠癌肺转移患者,效果良好。然而,目前对于肺转移尚无标准的手术指征。
我们回顾了1991年11月至2013年4月间94例行结直肠癌肺转移完全切除术的患者。计算肺转移瘤切除术后的累积生存率,并分析长期生存的预后因素。
男性60例,女性34例,中位年龄66岁。肺转移瘤切除术后5年生存率为45.5%。结肠癌和直肠癌患者的5年生存率分别为62.4%和33.8%(p = 0.030),肺切除术前癌胚抗原(CEA)水平正常和升高的患者5年生存率分别为57.0%和30.9%(p = 0.038)。多因素分析显示术前CEA水平是独立的预后因素。94例患者中有65例(69.1%)在肺转移瘤切除术后复发,对肝或肺或两者的复发病灶进行手术切除的患者比接受其他治疗或姑息治疗的患者生存更好。
手术切除为可切除的结直肠癌肺转移患者提供了延长生存期的机会。由于复发率高,建议术后仔细随访以早期发现,即使复发,如果病灶局限于肝或肺或两者,为了更好的生存也应考虑手术切除。